Introduction: For manufacturers pursuing approval of a generic PLGA-based injectable depot product, demonstrating PLGA polymer sameness for an ANDA submission […]
Introduction: Why Characterization of Long-Acting Biologics in PLGA Demands a Dedicated Framework The characterization of long-acting biologics encapsulated within poly(lactic-co-glycolic
Characterization of Long-Acting Biologics in PLGA Systems Read More »
Introduction The Glass Transition Temperature (Tg) of PLGA is far more than a routine material specification. It functions as the
Introduction: IVIVC for PLGA based Injectable Formulations has become increasingly important in the development of long-acting parenteral drug delivery systems.
In Vitro–In Vivo Correlation (IVIVC) for PLGA-Based Injectable Formulations Read More »
Introduction: When developing a next-generation injectable, implantable, or targeted therapy using poly(lactic-co-glycolic acid) (PLGA), one of the most consequential early
Introduction: Octreotide PLGA Characterization plays a pivotal role in the development and regulatory approval of generic long-acting injectable depots. For
Comparative Analytical Framework for PLGA Systems PLGA Implant vs Microsphere Characterization focuses on understanding how PLGA polymer structure affects the
Introduction: Reverse Engineering Risperidone PLGA Microspheres is a critical approach in modern pharmaceutical development, particularly for long-acting injectable formulations. By
Introduction: Exenatide PLGA Microsphere Characterization plays a pivotal role in the development of long-acting injectable formulations, particularly for GLP-1 analogs
Introduction: PLGA for Oncology Implant systems play a critical role in modern cancer therapy by enabling localized, sustained drug delivery
